Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
2023 Standout
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
2023 Standout
Works of Ann Cameron being referenced
Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohn's Disease.
2018
Nonresponse, partial response, and failure to achieve remission: humanistic and cost burden in major depressive disorder
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ann Cameron | 181 | 276 | 90 | 116 | 18 | 490 | |
| Eduardo A. Colón | 109 | 78 | 31 | 14 | 20 | 575 | |
| Hakan Kumbasar | 88 | 157 | 13 | 18 | 19 | 487 | |
| Edward Davidson | 272 | 130 | 74 | 36 | 19 | 566 | |
| Rama Malhotra | 129 | 134 | 38 | 27 | 18 | 544 | |
| Emma E. Walter | 278 | 194 | 57 | 96 | 19 | 569 | |
| Robert M. Baume | 73 | 178 | 78 | 106 | 17 | 550 | |
| Reinhilde Melles | 132 | 336 | 43 | 64 | 16 | 440 | |
| Christopher B. Harte | 234 | 259 | 24 | 113 | 26 | 560 | |
| Marianne Wikman | 166 | 244 | 47 | 29 | 18 | 451 | |
| Rosie King | 199 | 353 | 85 | 153 | 11 | 440 |
All Works
Login with ORCID to disown or claim papers
Loading papers...